International consensus guidelines on the management of cytomegalovirus in solid organ transplantation

Transplantation. 2010 Apr 15;89(7):779-95. doi: 10.1097/TP.0b013e3181cee42f.


Cytomegalovirus (CMV) remains one of the most common infections after solid organ transplantation, resulting in significant morbidity, graft loss, and occasional mortality. Management of CMV varies considerably among transplant centers. A panel of experts on CMV and solid organ transplant was convened by The Infectious Diseases Section of The Transplantation Society to develop evidence and expert opinion-based consensus guidelines on CMV management including diagnostics, immunology, prevention, treatment, drug resistance, and pediatric issues.

Publication types

  • Practice Guideline
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antiviral Agents / therapeutic use*
  • Child
  • Consensus
  • Consensus Development Conferences as Topic
  • Cytomegalovirus Infections / diagnosis
  • Cytomegalovirus Infections / drug therapy*
  • Cytomegalovirus Infections / immunology
  • Cytomegalovirus Infections / prevention & control*
  • Cytomegalovirus Vaccines*
  • Drug Resistance, Viral
  • Evidence-Based Medicine
  • Humans
  • Immunosuppressive Agents / adverse effects*
  • International Cooperation
  • Organ Transplantation / adverse effects*
  • Risk Assessment
  • Risk Factors
  • Treatment Outcome


  • Antiviral Agents
  • Cytomegalovirus Vaccines
  • Immunosuppressive Agents